Ticker
PPCBCompany Name
PROPANC BIOPHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares | Net Cash Flow - Issuance (Repayment) of Debt Securities | Net Cash Flow - Dividends & Other Cash Distributions | Shareholder Yield |
---|---|---|---|---|---|
6/30/2025 | $ 23.44M | $ 0 | $ 755.41K | $ 0 | -3.22% |
3/31/2025 | $ 0 | $ 11.97K | $ 722K | $ 0 | 0% |
12/31/2024 | $ 0 | $ 23.06K | $ 590.08K | $ 0 | 0% |
9/30/2024 | $ 0 | $ 23.06K | $ 784.19K | $ 0 | 0% |
6/30/2024 | $ 0 | $ 23.06K | $ 918.84K | $ 0 | 0% |
3/31/2024 | $ 0 | $ 111.08K | $ 679.84K | $ 0 | 0% |
12/31/2023 | $ 0 | $ 275K | $ 718.78K | $ 0 | 0% |
9/30/2023 | $ 0 | $ 375K | $ 594.85K | $ 0 | 0% |
6/30/2023 | $ 0 | $ 523.47K | $ 590.25K | $ 0 | 0% |
6/30/2022 | $ 0 | $ 724.29K | $ 766.5K | $ 0 | 0% |
(-1 * CF - Equity -1 * CF - Dividends -1 * CF - Debt) / Market Cap
(=) Shareholder Yield
Shareholder Yield for PROPANC BIOPHARMA INC is calculated as follows: (-1 * CF - Equity [ $ 724.29K ] -1 * CF - Dividends [ $ 0 ] -1 * CF - Debt [ $ 766.5K ]) / Market Cap [ $ 0 ]
(=) Shareholder Yield [ 0% ]
Minimum
Jun 30, 2025
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 3.48K |
---|---|
min | -33.43% |
max | 34.45% |
average | 0.58% |
median | 1.07% |
std | 11.12% |